New FDA QMSR: Its Role In Part 4 Compliance For Combination Products
Source: Drug Delivery Leader
The FDA’s release of the new Quality Management System Regulation (QMSR) significantly revises 21 CFR Part 820 Quality System Regulation and, in turn, Part 4 CGMP for combination products. The inclusion of ISO 13485 through reference brings the impact of global harmonization efforts to your doorstep, regardless of your organization’s role in the industry or its geographic jurisdiction.
access the Virtual Event!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.
Subscribe to Drug Delivery Leader
X
Subscribe to Drug Delivery Leader
This website uses cookies to ensure you get the best experience on our website. Learn more